TUESDAY, April 13, 2021 (HealthDay News) — Though playing youth sports comes with new pandemic-era precautions and some experts are linking these activities to community spread of COVID-19, many kids are still participating, according to a parent survey. In the survey, about three-quarters of parents said their child’s teams mostlyContinue Reading

MONDAY, April 12, 2021 (HealthDay News) — Once you’ve landed that coveted coronavirus vaccine appointment, you’ll likely have to fill out a form on your medical history and whether you’re allergic to any of the vaccine’s ingredients. But there could be another question waiting for you: Have you ever hadContinue Reading

MONDAY, April 12, 2021 (HealthDay News) — Older adults in long-term care develop detectible antibodies after COVID-19 vaccination, which may mean it’s safe to reopen these facilities, according to a new study. But because it’s unclear how long the antibodies last, researchers from University of Pittsburgh Medical Center (UPMC) sayContinue Reading

FRIDAY, April 9, 2021 (HealthDay News) — Doctors might have figured out why AstraZeneca’s COVID-19 vaccine may cause life-threatening blood clots in very rare cases. The discovery, made in a pair of reports published online Friday in the New England Journal of Medicine, could be key to the global rolloutContinue Reading

FRIDAY, April 9, 2021 (HealthDay News) — Doctors, nurses and other frontline health workers in U.S. emergency departments have struggled with significant mental health challenges during the COVID-19 pandemic, a new poll reveals. “As the nation moves into what many believe is a fourth wave of COVID, this study isContinue Reading

THURSDAY, April 8, 2021 (HealthDay News) — A new clinical trial will investigate whether people who are highly allergic or have what’s known as a mast cell disorder are at higher risk for a sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines. “The public understandably has been concernedContinue Reading

THURSDAY, April 8, 2021 (HealthDay News) — Two COVID-19 vaccines appear to work well against a rapidly spreading coronavirus variant that arose in California, but less effective against a variant that first emerged in South Africa, researchers report. “The good news is the California variant does not appear to beContinue Reading